← Insider buys
AKRO

Akero Therapeutics, Inc. · HEALTHCARE

Versant Venture Capital Vi, L.P. sold $1.0M of Akero Therapeutics, Inc.

10% owner

Sold$1,018,571
$20.04Price
50,837Shares
−2%Stake

What AKRO did after the filing

Prices for AKRO after this filing aren't in yet.

Traded Fri, Jan 10. Filed Wed, Jan 15, 4:53 PM ET, after the close. Not investment advice.